277. Lymphangiomatosis Clinical trials / Disease details
Clinical trials : 6 / Drugs : 2 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 51
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000014888 | 2014/06/01 | 19/08/2014 | Everolimus for the treatment of lymphangiomatosis, Gorham-Stout disease and vascular anomalies | Everolimus for the treatment of lymphangiomatosis, Gorham-Stout disease and vascular anomalies - Everolimus for vascular anomalies | Lymphangiomatosis, Gorham-Stout disease and vascular anomalies | Oral everolimus | Gifu university | NULL | Complete: follow-up complete | Not applicable | 30years-old | Male and Female | 30 | Phase 1 | Japan |